FDA Drug recall D-1584-2014
Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only
- FDA Drug
- Class III
- terminated
- Published 2014-09-24
On 2014-09-24 the FDA classified a Class III recall of Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only by Taro Pharmaceuticals U, citing failed Content Uniformity Specifications.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1584-2014 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2014-08-25 |
| Published | 2014-09-24 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Taro Pharmaceuticals U |
| Distribution | CA, HI, IL, MS, NH, OH, TX |
Product
Warfarin Sodium Tablets, USP Crystalline, 2 mg, 100 and 1000 Tablet Bottles, Rx Only. Mfd. by: Taro Pharmaceutical Industries, Ltd., Haifa Bay, Israel 26110. Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. 100 Tablet Bottle NDC: 51672-4028-1, 1000 Tablet Bottle NDC: 51672-4028-3.
Reason
Failed Content Uniformity Specifications.
Identifiers
| ndc | 51672-4027-1 |
|---|---|
| ndc | 51672-4027-3 |
| ndc | 51672-4027-7 |
| ndc | 51672-4027-0 |
| ndc | 51672-4028-1 |
| ndc | 51672-4028-3 |
| ndc | 51672-4028-7 |
| ndc | 51672-4028-0 |
| ndc | 51672-4029-1 |
| ndc | 51672-4029-3 |
| ndc | 51672-4029-7 |
| ndc | 51672-4029-0 |
| ndc | 51672-4030-1 |
| ndc | 51672-4030-3 |
| ndc | 51672-4030-7 |
| ndc | 51672-4030-0 |
| ndc | 51672-4031-1 |
| ndc | 51672-4031-3 |
| ndc | 51672-4031-7 |
| ndc | 51672-4031-0 |
| ndc | 51672-4032-1 |
| ndc | 51672-4032-3 |
| ndc | 51672-4032-7 |
| ndc | 51672-4032-0 |
| ndc | 51672-4033-1 |
| ndc | 51672-4033-3 |
| ndc | 51672-4033-7 |
| ndc | 51672-4033-0 |
| ndc | 51672-4034-1 |
| ndc | 51672-4034-3 |
| ndc | 51672-4034-0 |
| ndc | 51672-4035-1 |
| ndc | 51672-4035-3 |
| ndc | 51672-4035-0 |
| code_info | Lot #: 149400, Expiry: January 2016; Lot #: 149649, Expiry: January 2016. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Other recalls by Taro Pharmaceuticals U
- Hydrocortisone 1% & Acetic Acid 2% Otic Solution, 10 mL bottle, Rx only, Mfg by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada L6T…
FDA Drug · Class III · 2024-08-21 · Taro Pharmaceuticals U - Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%,15 g tubes, Rx only, Manufactured by: Taro Pharmaceuticals Industries Ltd
FDA Drug · Class III · 2022-04-06 · Taro Pharmaceuticals U - Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dis…
FDA Drug · Class I · 2022-01-19 · Taro Pharmaceuticals U - Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd
FDA Drug · Class II · 2021-02-10 · Taro Pharmaceuticals U - Kaiser Permanente Clotrimazole Cream USP, 1% Antifungal Cream, NET WT 1 oz (28.4 g), Manufactured by Taro Pharmaceuticals Inc
FDA Drug · Class II · 2020-12-23 · Taro Pharmaceuticals U
All Taro Pharmaceuticals U recalls
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1584-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.